{"id":"W3016646661","doi":"10.1136/annrheumdis-2019-216823","title":"Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network; Mount Sinai Hospital; Western University","funders":"Chugai Pharmaceutical; Genentech; Medac; Astellas Pharma; Ono Pharmaceutical; Eisai; Sanofi; Bayer HealthCare; Bristol-Myers Squibb; Eli Lilly and Company; CSL Behring; Alexion Pharmaceuticals; Immune Tolerance Network; GlaxoSmithKline; Bayer; Daiichi-Sankyo; Pfizer","keywords":"Medicine; Riociguat; Double blind; Placebo; Scleroderma (fungus); Double blinded; Placebo-controlled study; Randomized controlled trial; Internal medicine; Pathology; Pulmonary hypertension; Chronic thromboembolic pulmonary hypertension","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001536731,0.001211328,0.003001088,0.0003318878,0.000317852,0.0007682981,0.0007029702,0.001840641,0.004304053],"category_scores_gemma":[0.001236759,0.0004479978,0.001098882,0.0004230175,0.0006615247,0.0005318454,0.0002909684,0.001691545,0.0007266069],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004777443,"about_ca_system_score_gemma":0.0007090725,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006890249,"about_ca_topic_score_gemma":0.001615901,"domain_scores_codex":[0.9993555,0.0003380872,0.00004260919,0.0001147398,0.00005564027,0.00009336209],"domain_scores_gemma":[0.9995036,0.0001397566,0.0001248788,0.00003655256,0.00004919792,0.0001459579],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9640404,0.003319962,0.001460867,0.001861774,0.0009567478,0.0001094644,0.0000485517,0.000160087,0.004301873,0.0001036989,0.001201489,0.02243514],"study_design_scores_gemma":[0.9671602,0.02913734,0.002477145,0.00005345715,0.0002836007,0.00006255666,0.00001037748,0.0001057361,0.0001836177,0.0000337661,0.0004861454,0.000006008621],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9617586,0.02721774,0.000594732,0.0008428492,0.0006355122,0.004406576,0.0009097313,0.0002388912,0.003395471],"genre_scores_gemma":[0.9834705,0.006143194,0.001137842,0.001615289,0.0005962435,0.0036218,0.001117564,0.00001568675,0.002281796],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004304053,"threshold_uncertainty_score":0.01439852,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04725101955671286,"score_gpt":0.2643723640259998,"score_spread":0.2171213444692869,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}